Understanding Immunity to the COVID-19 Vaccines
Completed
- Conditions
- ImmunityCOVID-19Vaccine
- Registration Number
- NCT04664309
- Lead Sponsor
- Stanford University
- Brief Summary
The purpose of this study is to test over time immunity to the COVID-19 vaccines. Adults who are receiving COVID-19 vaccines will be invited to participate.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 43
Inclusion Criteria
- Adults who are receiving a COVID-19 vaccine
Exclusion Criteria
- Patients with special risks attendant to venipuncture
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of participants with immunity to COVID-19 vaccines over time 1 year
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie long-term immunity to SARS-CoV-2 vaccines in adult populations?
How do antibody titers and T-cell responses from NCT04664309 compare to standard-of-care vaccine regimens for SARS-CoV-2?
What biomarkers correlate with durable immune response in the Stanford University SARS-CoV-2 vaccine immunity study?
What adverse events were monitored in the NCT04664309 observational study of SARS-CoV-2 vaccine immunity?
How does the Stanford University SARS-CoV-2 vaccine immunity study inform vaccine strategies compared to other observational trials?
Trial Locations
- Locations (1)
Stanford University, Hospital, and Clinics
🇺🇸Stanford, California, United States
Stanford University, Hospital, and Clinics🇺🇸Stanford, California, United States